Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus’ replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...
That experience moved Hurley to seek out PrEP, shorthand for preexposure prophylaxis. The antiretroviral medication greatly ...
WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
A majority (91%) of HIV patients who received care through the Ryan White HIV/AIDS Program were virally suppressed in 2024, according to a new Health Resources and Services Administration (HRSA) ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. OXFORD, United Kingdom (StudyFinds.org) – A ...
Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...
News-Medical.Net on MSN
Expanded HIV treatment dramatically reduced orphanhood rates in Uganda
The scale-up of HIV treatment and prevention programs has led to remarkable declines in orphanhood rates in Rakai, Uganda, ...
"We were all responsible," says the man convicted of endangering partners. FRISCO, Texas, Sept. 18, 2009 — -- It was a novel case: a Texas man accused of knowingly infecting six former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback